Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Single Arm Phase II Trial of Zolbetuximab in Combination With mFOLFOX6 or CAPOX Chemotherapy in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers
Subjects will receive zolbetuximab with either CAPOX every 3 weeks or mFOLFOX6 every 2 weeks. The chemotherapy regimen chosen, mFOLFOX6 or CAPOX is per the tre…
Advanced Biliary Tract CancerMetastatic Biliary Tract Carcinoma
Estimated
~$10 – $7,500
Midhun MallaNCT07723534
Phase 3
A Phase 3, Multicenter, Randomized, Open-label, Study Evaluating the Efficacy and Safety of Nanvuranlat in Patients With Previously Treated Advanced Biliary Tract Cancer
This study is designed to 1) select a dose regimen for continued development and 2) evaluate nanvuranlat versus Physicians Best Choice (PBC) (FOLFOX, FOLFIRI, …
Advanced Biliary Tract CancerBiliary Tract Cancer (BTC)
Estimated
~$10 – $8,750
J-Pharma Co., Ltd.NCT07265674